Annual Long Term Debt
$0.00
-$6.53 M-100.00%
31 December 2023
Summary:
Eupraxia Pharmaceuticals Common Stock annual long term debt is currently $0.00, with the most recent change of -$6.53 million (-100.00%) on 31 December 2023. During the last 3 years, it has fallen by -$7.37 million (-100.00%). EPRX annual long term debt is now -100.00% below its all-time high of $7.37 million, reached on 01 December 2021.EPRX Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$14.30 K
-$20.70 K-59.14%
01 September 2024
Summary:
Eupraxia Pharmaceuticals Common Stock quarterly long term debt is currently $14.30 thousand, with the most recent change of -$20.70 thousand (-59.14%) on 01 September 2024. Over the past year, it has increased by +$5600.00 (+64.37%). EPRX quarterly long term debt is now -99.84% below its all-time high of $8.86 million, reached on 01 December 2022.EPRX Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EPRX Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -100.0% | +64.4% |
| 3 y3 years | -100.0% | -99.8% |
| 5 y5 years | -100.0% | -92.6% |
EPRX Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -100.0% | -99.8% | ||
| 5 y | 5 years | -100.0% | -99.8% | ||
| alltime | all time | -100.0% | -99.8% |
Eupraxia Pharmaceuticals Common Stock Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $14.30 K(-59.1%) |
| June 2024 | - | $35.00 K(>+9900.0%) |
| Dec 2023 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2023 | - | $8700.00(-80.5%) |
| June 2023 | - | $44.60 K(-99.5%) |
| Dec 2022 | $6.53 M | - |
| Dec 2022 | - | $8.86 M(+19.7%) |
| Sept 2022 | - | $7.40 M(-3.3%) |
| June 2022 | - | $7.65 M(-0.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $7.70 M(+4.5%) |
| Dec 2021 | $7.37 M(+4632.7%) | $7.37 M(+1.9%) |
| Sept 2021 | - | $7.23 M(+2.1%) |
| June 2021 | - | $7.08 M(+4769.1%) |
| Mar 2021 | - | $145.50 K(-6.6%) |
| Dec 2020 | $155.80 K(-19.0%) | $155.80 K(-1.5%) |
| Sept 2020 | - | $158.20 K(-17.7%) |
| Dec 2019 | $192.30 K(>+9900.0%) | $192.30 K |
| Dec 2018 | $0.00(-100.0%) | - |
| Dec 2017 | $4100.00 | - |
FAQ
- What is Eupraxia Pharmaceuticals Common Stock annual long term debt?
- What is the all time high annual long term debt for Eupraxia Pharmaceuticals Common Stock?
- What is Eupraxia Pharmaceuticals Common Stock annual long term debt year-on-year change?
- What is Eupraxia Pharmaceuticals Common Stock quarterly long term debt?
- What is the all time high quarterly long term debt for Eupraxia Pharmaceuticals Common Stock?
- What is Eupraxia Pharmaceuticals Common Stock quarterly long term debt year-on-year change?
What is Eupraxia Pharmaceuticals Common Stock annual long term debt?
The current annual long term debt of EPRX is $0.00
What is the all time high annual long term debt for Eupraxia Pharmaceuticals Common Stock?
Eupraxia Pharmaceuticals Common Stock all-time high annual long term debt is $7.37 M
What is Eupraxia Pharmaceuticals Common Stock annual long term debt year-on-year change?
Over the past year, EPRX annual long term debt has changed by -$6.53 M (-100.00%)
What is Eupraxia Pharmaceuticals Common Stock quarterly long term debt?
The current quarterly long term debt of EPRX is $14.30 K
What is the all time high quarterly long term debt for Eupraxia Pharmaceuticals Common Stock?
Eupraxia Pharmaceuticals Common Stock all-time high quarterly long term debt is $8.86 M
What is Eupraxia Pharmaceuticals Common Stock quarterly long term debt year-on-year change?
Over the past year, EPRX quarterly long term debt has changed by +$5600.00 (+64.37%)